QDELQuidelOrtho Corporation

1. Sep 23, 2026On September 23, 2026, QuidelOrtho Corporation (the “Company”) entered into Amendment No. 1 (the “Amendment”) to its existing credit agreement, dated as of August 21, 2025 (as amended by the Amendment, the “Credit Agreement”), by and among the Company, as borrower, Bank of America, N.A., as administrative agent and …Material agreement entered · Form 8-K
2. Aug 6, 2026QuidelOrtho Reports Second Quarter 2026 Financial Results.Earnings release · press release
3. Jun 23, 2026Announcement of New Chief Financial Officer The Board of Directors of QuidelOrtho Corporation (the “Company”) has appointed Micah Young to serve as the Company’s Chief Financial Officer and principal financial officer, effective as of July 6, 2026 (the “Effective Date”)Director or officer change · Form 8-K
4. May 5, 2026QuidelOrtho Reports First Quarter 2026 Financial Results.Earnings release · press release
5. Apr 15, 2026QuidelOrtho Announces Preliminary Revenue for the First Quarter 2026 and Provides Update on Full-Year 2026 Guidance.Earnings release · press release
6. Mar 24, 2026On March 18, 2026, Michelle A. Hodges, the Chief Legal Officer and Corporate Secretary of QuidelOrtho Corporation (the “Company”), notified the Company of her plans to retire from these roles, effective March 23, 2026 (the “Effective Date”), to be concurrent with the Company’s appointment of a successor Chief Legal …Director or officer change · Form 8-K
7. Feb 13, 2026On February 9, 2026, Joseph M. Busky, the Chief Financial Officer and principal financial officer of QuidelOrtho Corporation (the “Company”), notified the Company of his plans to retire effective as of June 30, 2026.Director or officer change · Form 8-K
8. Feb 11, 2026QuidelOrtho Reports Fourth Quarter and Full-Year 2025.Earnings release · press release
9. Feb 5, 2026On January 30, 2026, Matthew W. Strobeck, a member of the board of directors (the “Board”) of QuidelOrtho Corporation (the “Company”), provided notice to the Board of his decision not to stand for re-election at the Company’s 2026 annual stockholders meeting (the “Annual Meeting”)Director or officer change · Form 8-K
10. Nov 10, 2025QuidelOrtho Third Quarter 2025 Financial Results.Regulation FD disclosure · press release
11. Nov 5, 2025QuidelOrtho Reports Third Quarter 2025 Financial Results.Earnings release · press release

Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.